XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value of Financial Instruments (Details-4) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]    
Beginning balance, $ (2,604) $ (866)
Realized and unrealized gains (losses):    
Included in regulatory assets 878 (2,874)
Included in earnings [1] (2,204) (4,671)
Settlements 2,204 4,671
Ending balance, $ (1,726) $ (3,740)
[1] MGE's exchange-traded derivative contracts, over-the-counter party transactions, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset in the financial statements with a corresponding regulatory asset or liability.